Skyscape Web Viewer : TNM Cancer Staging System : Main Index

View All
Clinical stage (cTNM) and overall survival in patients diagnosed with gastric cancer, stratified by clinical stage groupings, based on NCDB data (2004-2008; median follow-up, 12 months; n = 7,306)
Clinical stage and 1-, 3-, and 5-year and median overall survivals in patients diagnosed with gastric cancer, stratified by clinical stage groupings, based on NCDB data
Clinical stage and 1-, 3-, and 5-year and median overall survivals in patients with gastric cancer who received curative or palliative surgery, stratified by clinical stage groupings, based on Shizuoka Cancer Center data
Clinical stage and overall survival in patients with gastric cancer who received curative or palliative surgery, stratified by clinical stage groupings, based on Shizuoka Cancer Center data (2002-2015; median follow-up, 47 months; n = 4,091)
Clinical T1a (left) is defined as a tumor with an incidental histologic finding in 5% or less of tissue resected
Clinical T2c is defined as a tumor that involves both sides
Clinical T2 is defined as a tumor that is palpable and confined within the prostate
CLL
Overall survival according to pathological N-category, AJCC 7th edition
Overall survival according to pathological T-category, AJCC 7th edition
Overall survival according to the N descriptors for clinically staged tumors (From Asamura et al
Overall survival according to the N descriptors for pathologically staged tumors including all types of resection (R0, R1 and R2) (From Asamura et al
Overall survival according to the proposed T categories for the 8th Edition of the TNM classification for clinically staged T1-T4N0M0 tumors
Overall survival according to the proposed T categories for the 8th Edition of the TNM classification for pathologically staged T1-T4N0M0R0 tumors
Overall survival according to “best stage” N-category, AJCC 8th edition
Overall survival according to “best stage” T-category, AJCC 8th edition
Overall survival according to “best” overall stage, AJCC 8th edition
Overall survival according to “best” overall stage, AJCC 8th edition, for a) cases with epithelioid histology
Overall survival according to “best” overall stage, AJCC 8th edition, for cases with non-epithelioid histology
Overall survival after surgical resection of perihilar cholangiocarcinoma at Nagoya University, Japan
Overall Survival based on 7th Edition AJCC/UICC stage groupings using 8th edition T and N criteria
Overall survival based on 7th edition AJCC/UICC Stage groupings with 8th edition T and N criteria
Overall survival based on 8thEdition N criteria (MSKCC-PMH Data)
Overall Survival based on 8thEdition N criteria that incorporate ENE as a prognostic factor
Overall survival based on 8th Edition N-Stage criteria (MSKCC-PMH Data)
Overall Survival based on 8th edition N-Stage criteria that incorporate ENE as a prognostic factor
Overall Survival based on 8th edition T-Stage criteria
Overall survival based on 8th Edition T-Stage criteria (MSKCC-PMH Data)
Overall Survival based on Kaplan Meier methods were used to perform cancer-specific analyses predicting overall survival as the endpoint on a population of oral cavity cancer patients from MSKCC and PMH
Overall survival comparisons between adjacent stage categories